Suchergebnisse - "Tarantino, Paolo"

PubPharm (7)

1

Detecting and Managing T-DXd-Related Interstitial Lung Disease : The Five "S" Rules

enthalten in: JCO oncology practice | 2023

von Tarantino, P. | Tolaney, S.

CommentOn: JCO Oncol Pract. 2023 Aug;19(8):539-546. - PMID 37207306

2

Response to letter entitled : Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer"

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Tarantino, P. | Nicolò, E. | Curigliano, G.

CommentOn: Front Mol Biosci. 2022 Mar 15;9:834651. - PMID 35372498

3

Association of Hormone Receptors With Clinical Outcomes in Patients With ERBB2-Low Breast Cancer-Reply

enthalten in: JAMA oncology | 2023

von Tarantino, P. | Tayob, N. | Tolaney, S.

CommentOn: JAMA Oncol. 2023 Jan 1;9(1):146-147. - PMID 36326737

4

The Dawn of the Antibody-Drug Conjugates Era : How T-DM1 Reinvented the Future of Chemotherapy for Solid Tumors

enthalten in: Cancer research | 2022

von Tarantino, P. | Tolaney, S.

CommentOn: Cancer Res. 2008 Nov 15;68(22):9280-90. - PMID 19010901

5

Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer-Should We Go "All In"?-Reply

enthalten in: JAMA oncology | 2022

von Tarantino, P. | Parsons, H. | Tolaney, S.

CommentOn: JAMA Oncol. 2022 Apr 01;8(4):629-635. - PMID 35024766

6

Mastering the Use of Novel Anti-HER2 Treatment Options

enthalten in: JCO oncology practice | 2021

von Tarantino, P. | Trapani, D. | Curigliano, G.

CommentOn: JCO Oncol Pract. 2021 Oct;17(10):594-604. - PMID 34077236

7

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

enthalten in: The New England journal of medicine | 2020

von Tarantino, P. | Curigliano, G.

CommentOn: N Engl J Med. 2020 May 14;382(20):1894-1905. - PMID 32402160

1
[1]